Article
A novel ciprofloxacin-resistant subclade of H58 Salmonella Typhi is associated with fluoroquinolone treatment failure.
eLife - 11 Mar 2016
Pham Thanh Duy, Karkey Abhilasha, Dongol Sabina, Ho Thi Nhan, Thompson Corinne N, Rabaa Maia A, Arjyal Amit, Holt Kathryn E, Wong Vanessa, Tran Vu Thieu Nga, Voong Vinh Phat, Ha Thanh Tuyen, Pradhan Ashish, Shrestha Saroj Kumar, Gajurel Damoder, Pickard Derek, Parry Christopher M, Dougan Gordon, Wolbers Marcel, Dolecek Christiane, Thwaites Guy E, Basnyat Buddha, Baker Stephen
Abstract excerpt
The interplay between bacterial antimicrobial susceptibility, phylogenetics and patient outcome is poorly understood. During a typhoid clinical treatment trial in Nepal, we observed several treatment failures and isolated highly fluoroquinolone-resistant Salmonella Typhi (S. Typhi). Seventy-eight S. Typhi isolates were genome sequenced and clinical observations, treatment failures and fever clearance times (FCTs)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
